Lisa Ricciardi insider trades: Cognition Therapeutics (CGTX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Lisa reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 31, 2025 | CGTX | ↑ Buy | 38,851 | $0.77 | $30K | By Spouse | Feb 4, 2025 (4d) |
| Mar 14, 2024 | CGTX | ↑ Buy | 5,700 | $1.75 | $10K | Direct | Mar 14, 2024 (0d) |
| Nov 15, 2022 | CGTX | ↑ Buy | 12,000 | $1.30 | $16K | Direct | Nov 16, 2022 (1d) |
| Oct 13, 2021 | CGTX | ↑ Buy | 12,500 | $12.00 | $150K | Direct | Oct 14, 2021 (1d) |
| Jul 25, 2017 | CFRX | ↑ Buy | 9,600 | $1.24 | $12K | Direct | Jul 26, 2017 (1d) |
| May 12, 2015 | CMRX | ↑ Buy | 1,950 | $38.54 | $75K | Direct | May 14, 2015 (2d) |
| Nov 24, 2008 | SEPR | ↑ Buy | 4,000 | $11.85 | $47K | Direct | Nov 25, 2008 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Lisa Ricciardi's insider trades
Lisa Ricciardi is CEO & President at Cognition Therapeutics (CGTX). Since Nov 24, 2008, Lisa has reported 7 open-market purchases worth $340K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (16 filings), shares withheld for taxes (7 filings), other transactions (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CGTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.